Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy

Journal of Urology

Volumn 190, Issue 5, 2013, Pages 1769-1775

  Issa, Muta M ^a   Al Qassab, Usama A ^a   Hall, John ^a   Ritenour, Chad W M ^a   Petros, John A ^a   Sullivan, Jerry W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Needle; Postoperative complications; Prostate; Prostatic neoplasms; Sepsis

Indexed keywords

AGAR; ANTIBIOTIC AGENT; BISACODYL; FORMALDEHYDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE;

ADULT; AGED; ARTICLE; BIOPSY NEEDLE; BLOOD CULTURE; DISINFECTION; ESCHERICHIA COLI; EX VIVO STUDY; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; RETROSPECTIVE STUDY; SEPSIS; URINARY TRACT INFECTION; URINE CULTURE;

EID: 84888637920     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.04.134     Document Type: Article

References (30)

1. Loeb S, Carter HB, Berndt SI et al: Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011; 186: 1830.
2. Nam RK, Saskin R, Lee Y et al: Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963.
3. Wagenlehner FM, van Oostrum E, Tenke P et al: Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 2013; 63: 521.
4. The Center for Disease Dynamics, Economics & Policy: Fluoroquinolone-Resistant Escherichia coli. Available at www.cddep.org/ resistancemap/bug-drug/EC-FQ. Accessed March 27, 2013.
5. Wolf JS Jr, Bennett CJ, Dmochowski RR et al: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008; 179: 1379.
6. Duplessis CA, Bavaro M, Simons MP et al: Rectal cultures before transrectal ultrasoundguided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 2012; 79: 556.
7. Taylor AK, Zembower TR, Nadler RB et al: Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012; 187: 1275.
8. Taylor S, Margolick J, Abughosh Z et al: Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 2013; 111: 946.
9. Liss MA, Chang A, Santos R et al: Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 2011; 185: 1283.
10. Issa MM, Bux S, Chun T et al: A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol 2000; 164: 397.
11. Issa MM, Zasada W, Ward K et al: The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy. Cancer Detect Prev 2006; 30: 269.
12. Abd TT, Goodman M, Hall J et al: Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans. Urology 2011; 77: 541.
13. El-Naggar MY, Akeila MA, Turk HA et al: Evaluation of in vitro antibacterial activity of some disinfectants on Escherichia coli serotypes. J Gen Appl Microbiol 2001; 47: 63.
14. United States Environmental Protection Agency: 2012 Edition of the Drinking Water Standards and Health Advisories. EPA Publication 822- S-12-001 April 2012. Available at http://water.epa.gov/action/advisories/drinking/upload/ dwstandards2012.pdf. Accessed March 20, 2013.
15. Qadeer MA and Vargo JJ: Approaches to the prevention and management of radiation colitis. Curr Gastroenterol Rep 2008; 10: 507.
16. Bootsma AM, Laguna Pes MP, Geerlings SE et al: Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 2008; 54: 1270.
17. Schaeffer AJ, Montorsi F, Scattoni V et al: Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int 2007; 100: 51.
18. Lange D, Zappavigna C, Hamidizadeh R et al: Bacterial sepsis after prostate biopsyea new perspective. Urology 2009; 74: 1200.
19. Abughosh Z, Margolick J, Goldenberg SL et al: A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 2013; 189: 1326.
20. Carignan A, Roussy JF, Lapointe V et al: Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 2012; 62: 453.
21. Adibi M, Hornberger B, Bhat D et al: Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 2013; 189: 535.
22. Zaytoun OM, Anil T, Moussa AS et al: Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors. Urology 2011; 77: 910.
23. Sieber PR, Rommel FM, Theodoran CG et al: Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007; 70: 498.
24. Feliciano J, Teper E, Ferrandino M et al: The incidence of fluoroquinolone resistant infections after prostate biopsyeare fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952.
25. Mosharafa AA, Torky MH, El Said WM et al: Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011; 78: 511.
26. Akduman B, Akduman D, Tokgöz H et al: Longterm fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 2011; 78: 250.
27. Johnson L, Sabel A, Burman WJ et al: Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008; 121: 876.
28. Patel U, Dasgupta P, Amoroso P et al: Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 2012; 109: 1781.
29. Hillier S, Roberts Z, Dunstan F et al: Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 2007; 60: 92.
30. Shigehara K, Miyagi T, Nakashima T et al: Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008; 14: 40.